Regardless of whether it's toys, cars, or high-tech gadgets, many U.S. companies have outsourced what they manufacture to ...

After much delay, Novartis has finally won a key FDA go-ahead for Pluvicto, opening up the radioligand therapy to a much broader prostate cancer population. The new approval, which triples ...

The drug's effects lasted six months with no major side effects, according to new research presented in Chicago Sunday at an ...

Bearish flow noted in Novartis (NVS) with 1,936 puts trading, or 3x expected. Most active are Apr-25 105 puts and Apr-25 110 puts, with total volume in those strikes near 1,100 contracts.

Novartis (NVS) announced that the Food and Drug Administration approved Pluvicto for patients with prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer who ...

Eli Lilly’s experimental drug, lepodisiran, reduces lipoprotein(a) (Lp[a]) levels by an average of 93.9 per cent in a ...

Avengers: Doomsday received an upgraded logo, which was unveiled on Wednesday. The new logo was met with disapproval from ...

Novartis: 1996 – 2013 Dr Daniel Vasella was the first CEO of the newly merged company. Vasella was hired by Sandoz back in 1988 and remained there until 1992 when he was promoted to CEO of its ...

A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals ...

EXCLUSIVE: Dubai-based global management and production company 75East has signed Iranian-American filmmaker and animator Liam LoPinto, whose 2023 animated short film The Old Young Crow made waves ...